Mushroom consumption and risk of gastric cancer: a pooled analysis within the stomach cancer pooling project and a combined meta-analysis with other observational studies

Autores da FMUP
Participantes de fora da FMUP
- Ba, Djibril M.
- Ssentongo, Paddy
- Pelucchi, Claudio
- Negri, Eva
- Palli, Domenico
- Ferraroni, Monica
- Zhang, Zuo-Feng
- Yu, Guo-Pei
- Tsugane, Shoichiro
- Hidaka, Akihisa
- Hamada, Gerson Shigueaki
- Zaridze, David
- Maximovich, Dmitry
- Obon-Santacana, Mireia
- Alvarez-Alvarez, Laura
- Vioque, Jesus
- Garcia de la Hera, Manoli
- Lopez-Carrillo, Lizbeth
- Lopez-Cervantes, Malaquias
- Mu, Lina
- Lagiou, Areti
- Lagiou, Pagona
- Boffetta, Paolo
- Camargo, Maria Constanza
- Curado, Maria Paula
- La Vecchia, Carlo
- Muscat, Joshua
Unidades de investigação
Abstract
Edible mushrooms have high concentrations of vitamins and minerals. They are considered `functional foods' for their disease-prevention properties. Mushroom consumption may reduce the risk of gastric cancer, the fifth most common cancer worldwide. We investigated the association between mushroom consumption and gastric cancer risk in a pooled analysis within the Stomach Cancer Pooling (StoP) Project and in a meta-analysis that also included previously published studies. A total of 3900 gastric cancer cases and 7792 controls from 11 studies were included in the StoP analysis. Mushroom consumption was measured using food frequency questionnaires. Higher mushroom consumption was associated with a lower risk of gastric cancer [relative risk (RR) for the highest vs. lowest consumption categories, 0.82; 95% confidence interval (CI), 0.71-0.95]. The corresponding RRs were 0.59 (95% CI, 0.26-1.33) in a meta-analysis of four previously published studies and 0.77 for all studies combined (95% CI, 0.63-0.95; n = 15 studies). In geographic subgroup analysis, the pooled risk in Western Pacific countries was (RR, 0.59; 95% CI, 0.40-0.87; n = 6). The stronger effect in Asian countries may reflect high level of antioxidants in mushroom species consumed in Asia.
Dados da publicação
- ISSN/ISSNe:
- 1473-5709, 0959-8278
- Tipo:
- Article
- Páginas:
- 222-228
- Link para outro recurso:
- www.scopus.com
EUROPEAN JOURNAL OF CANCER PREVENTION Lippincott Williams and Wilkins Ltd.
Citações Recebidas na Web of Science: 2
Citações Recebidas na Scopus: 2
Documentos
- Não há documentos
Filiações
Filiações não disponíveis
Keywords
- epidemiology; gastric cancer; meta-analysis; mushrooms; pooled analysis
Proyectos asociados
Breast cancer heterogeneity - etiology, clinical management, use of health resources and survival
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2022
Longitudinal Assessment of Cognitive Decline in Breast and Prostate Cancer Survivors
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico (Cognitive Decline) . 2022
Healthcare use among cancer patients and their partners in different phases of the cancer pathway
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2021
Reshaping organized cervical cancer screening: strategies to increase the adherence and reduce invitation costs
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
Using pooled analyses based on individual participant data for a finer assessment of gastric cancer etiology
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2020
RISK AND SURVIVAL OF GASTRIC CANCER RELATES SECOND PRIMARY TUMOURS: A COMPETING RISKS FRAMEWORK
Investigador Principal: Nuno Miguel de Sousa Lunet
Estudo Clínico Académico . 2019
Citar a publicação
Ba DM,Ssentongo P,Pelucchi C,Negri E,Palli D,Ferraroni M,Zhang Z,Yu G,Tsugane S,Hidaka A,Hamada GS,Zaridze D,Maximovich D,Obon M,Alvarez L,Vioque J,Garcia de la Hera M,Lopez L,Lopez M,Mu L,Lagiou A,Lagiou P,Boffetta P,Camargo MC,Curado MP,Lunet N,La Vecchia C,Muscat J. Mushroom consumption and risk of gastric cancer: a pooled analysis within the stomach cancer pooling project and a combined meta-analysis with other observational studies. Eur. J. Cancer Prev. 2023. 32. (3):p. 222-228. IF:2,400. (4).